Dr. Mahony joined the Kovina board as a director in June 2021. From 2011 until her retirement in August 2018, she served as Senior Vice President and President of Lilly Oncology and was a member of the executive committee at Eli Lilly and Company. Before that, Dr. Mahony served in a variety of leadership roles at Lilly including Senior Vice President Human Resources and Diversity, President and General Manager Lilly Canada, and Executive Director Global Product Development. Dr. Mahony joined Lilly in 2000 after more than a decade in sales and marketing roles for Schering-Plough, Amgen and Bristol-Myers Squibb. Currently she serves as a member of the board of directors of four publicly traded companies; Horizon Therapeutics plc, Vifor Pharma AG, Assembly Biosciences Inc, and Zymeworks, Inc. She also serves on the board of the Chordoma Foundation, a nonprofit organization dedicated to improving the lives of those affected by Chordoma. Dr. Mahony earned a Bachelor of Science and Doctor of Philosophy (PhD) in pharmacy from Aston University, as well as a Master of Business Administration from London Business School in the UK. She was awarded an honorary doctorate from Aston University and has been recognized as one of the Indianapolis Business Journal's “Women of Influence.”